주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-19 11:39 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
425 )
기사목록 보기 형태
제목형
요약형
포토형
‘Korea’s biopharma sector has sufficient potential’
Lee Hye-seon
2019.03.04 14:39
BioGenetics inks deal to supply biliary tract cancer drug in Korea
Lee Hye-seon
2019.02.28 15:36
Chong Kun Dang topped clinical trials in 2018
Lee Hye-seon
2019.02.28 10:44
Korea, China to cooperate for regulations on drugs, medical devices, cosmetics
Lee Hye-seon
2019.02.27 22:31
Korea’s 30th novel drug K-Cab to get insurance benefit from March
Lee Hye-seon
2019.02.27 15:10
Korea to phase out consigned bioequivalence tests
Lee Hye-seon
2019.02.27 11:27
Yuclid’s antiplatelet effect confirmed in patients undergoing carotid artery stenting
Lee Hye-seon
2019.02.26 14:31
Medical cannabis imports allowed only through orphan drug center
Lee Hye-seon
2019.02.22 10:54
Korea to revise limited exclusive sales rights approval
Lee Hye-seon
2019.02.21 11:19
Regulator to inspect 12 biopharmaceutical plants overseas
Lee Hye-seon
2019.02.20 15:32
Pharma Research Bio wins nod to export botulinum toxin
Lee Hye-seon
2019.02.19 15:44
Korea to raise vaccine self-sufficiency to 57% by 2020
Lee Hye-seon
2019.02.19 14:37
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기